New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
15:46 EDTNBYDoctor uses NovaBay product in flesh-eating disease treatment, SFGate says
Dr. John Crew has used NeutroPhase, a NovaBay Pharmaceuticals product approved for cleaning wounds, as part of a new technique he successfully implemented to treat necrotizing fasciitis, which is otherwise known as "flesh-eating disease," while trying to avoid the repeated surgeries typically associated with treatment of the condition, reported SFGate yesterday. Reference Link
News For NBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2014
07:00 EDTNBYNovaBay signs distribution agreement with McKesson
NovaBay (NBY) has signed a nationwide distribution agreement with McKesson Corporation (MCK). The agreement covers NovaBay’s i-LidTM Cleanser, a prescription lid and lash hygiene product for the management of debilitating eye conditions such as blepharitis, Meibomian gland dysfunction and associated dry eye.
November 12, 2014
07:09 EDTNBYNovaBay reports Q3 EPS (8c), consensus (9c)
Reports Q3 revenue $90,000, one estimate $200,000.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use